[
    [
        {
            "time": "2018-01-05",
            "original_text": "Look at Eli Lilly’s 4Q17 Revenue",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "4Q17",
                    "Revenue"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Look at Eli Lilly’s 4Q17 Revenue",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-02-22",
            "original_text": "European ADRs Move Higher in Thursday Trading",
            "features": {
                "keywords": [
                    "European",
                    "ADRs",
                    "Move Higher",
                    "Thursday Trading"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "international",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "European ADRs Move Higher in Thursday Trading",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-02-22",
            "original_text": "Health Care Sector Update for 02/22/2018: SGMO, GILD, CLVS, NVO, NVS, BKD",
            "features": {
                "keywords": [
                    "Health Care",
                    "Sector Update",
                    "SGMO",
                    "GILD",
                    "CLVS",
                    "NVO",
                    "NVS",
                    "BKD"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Health Care Sector Update for 02/22/2018: SGMO, GILD, CLVS, NVO, NVS, BKD",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "Novo Nordisk successfully kicks off final-stage trials for first diabetes pill",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "final-stage trials",
                    "diabetes pill"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Novo Nordisk successfully kicks off final-stage trials for first diabetes pill",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]